Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Diagnostic Performance of the DISQVER® Metagenomic Sequencing Tool for the Identification of Pathogens in Febrile Neutropenic Haemato-oncology Patients

NCT06075888 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT06075888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06075888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Diagnostic Performance of the DISQVER® Metagenomic Sequencing Tool for the Identification of Pathogens in Febrile Neutropenic Haemato-oncology Patients
Lead sponsor
Poitiers University Hospital
Phase
Not applicable
Overall status
Terminated
Start date
January 12, 2024
Completion date
June 15, 2026
Enrollment
184 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

immunodepressed patients (hemato-oncology)